Latest Asian Markets News

Lark Distilling Co. has reported its sixth consecutive quarter of sales growth, with net sales rising 11% to $5 million in Q2 FY26, as it prepares to launch a refreshed brand portfolio domestically and internationally.

BCI Minerals has reported solid progress on its Mardie Salt Operation and Potash Project, reaching 77% construction completion and hitting critical operational targets including pond brine density and commissioning of trial crystallisers. The company also strengthened its financial position through debt facility draws and convertible note conversions.

Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

VRX Silica Limited has expanded its Arrowsmith North project’s offtake commitments by 550,000 tonnes annually and appointed Pareto Securities to manage debt financing, reinforcing its path to production.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.

RLF AgTech's second-year durian trial in Vietnam confirms a 38% yield increase and significant plant growth improvements, suggesting a potential 10-fold return on investment with minimal cost rise.

DigiCo Infrastructure REIT appoints Michael Juniper as CEO, signaling a strategic push into advanced data centre development amid rising cloud and AI demand. Chris Maher shifts focus to government relations, underscoring regulatory challenges ahead.

Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.

VRX Silica Limited has raised $2.1 million through a share placement to fund critical pre-construction activities at its Arrowsmith North Silica Sand Project, aiming to strengthen its position in high-quality silica sand markets.

SPC Global Holdings delivered a transformational FY25 with robust financial results and strategic international growth, setting the stage for a confident 25% EBITDA increase in FY26.